The varying impacts of COVID-19 and its related measures in the UK: A year in review

Zhou, Muzhi; Kan, Man-Yee

doi:10.1371/journal.pone.0257286

Cited by 68 publications

(69 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While no longitudinal data are available on PTSD changes over time during the COVID-19 pandemic in cancer patients, this further increase in symptoms was recently reported in a UK representative population survey. 27 However, we did not observe the same trend at the third lockdown, which could be explained by the advent of vaccination and the ability of patients to cope better.…”

Section: Discussioncontrasting

confidence: 58%

See 1 more Smart Citation

Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study

Bastien¹,

Lefèvre‐Arbogast

Lequesne

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Cancer patients may be particularly vulnerable to psychological consequences of the COVID-19 pandemic and successive lockdowns. We studied the prevalence and evolution of post-traumatic stress disorder (PTSD) symptoms in cancer patients during the pandemic waves, and investigated factors associated with high symptoms. Methods: COVIPACT is a one-year longitudinal prospective study of French patients with solid/hematologic malignancy receiving treatment during the first nationwide lockdown. PTSD symptoms were measured every 3 months from April 2020 using the Impact of Event Scale-Revised. Patients also completed validated questionnaires on quality of life (QoL), cognitive complaints and insomnia, and a survey on their COVID-19 lockdown experience. Results: Longitudinal analyses involved 386 patients with at least one PTSD assessment after baseline (median age 63, 76% female). Among them, 21.5% had moderate/severe PTSD symptoms during the first lockdown. The rate of patients reporting PTSD symptoms decreased at lockdown release (13.6%), increased again at second lockdown (23.2%), and slightly declined from the second release period (22.7%) to the third lockdown (17.5%). Patients were grouped into three trajectories of evolution. Most patients had stable low symptoms throughout the period, 6% had high baseline symptoms slowly decreasing over time, and 17.6% had moderate symptoms worsening during second lockdown. Female sex, feeling socially isolated, worrying about COVID-19 infection, and using psychotropic drugs were associated with PTSD symptoms. PTSD symptoms were associated with impaired QoL, sleep and cognition. Conclusions: Around a quarter of cancer patients presented high and persistent PTSD symptoms over the first year of the COVID-19 pandemic and may benefit from psychological support.

show abstract

Section: Discussioncontrasting

confidence: 58%

“…However, our data are consistent with prevalence estimates from a meta-analysis in the general population, 5 and longitudinal trends over the repeated pandemic waves. 7,26,27…”

Section: Discussionmentioning

confidence: 99%

Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study

Bastien¹,

Lefèvre‐Arbogast

Lequesne

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…The effect of being a key worker on sleep disruption is stronger for women. Women are more likely to work in the frontline as key workers 13. Female key workers face challenges from their professions that are more front-facing and exposed to the virus, putting themselves and their families at risk, and from their growing family responsibilities.…”

Section: Discussionmentioning

confidence: 99%

“…COVID-19 has brought considerable and deep impacts to people’s social life and daily routines, but the burden is not equally distributed by gender 12. For example, since gender norms and predominant working patterns in the UK position men as the primary earners and women as the primary care givers, the spatial boundary between work and family life was blurred during the work-from-home period 13. Second, although some preliminary studies exist, they examine only one sample and do not focus in detail on gender differences.…”

Section: Introductionmentioning

confidence: 99%

Gender differences in sleep disruption during COVID-19: cross-sectional analyses from two UK nationally representative surveys

2022

View full text Add to dashboard Cite

ObjectiveCOVID-19 related measures have impacted sleep on a global level. We examine changes in sleep problems and duration focusing on gender differentials.DesignCross-sectional analyses using two nationally representative surveys collected during the first and second month after the 2020 lockdown in the UK.Setting and participantsParticipants (age 17 years and above) from the first wave of the Understanding Society COVID-19 Study are linked to the most recent wave before the pandemic completed during 2018 and 2019 (n=14 073). COVID-19 Survey Data was collected from 2 to 31 May 2020 (n=8547) with participants drawn from five nationally representative cohort studies in the UK.AnalysisWe conducted bivariate analyses to examine gender gaps in change in sleep problems and change in sleep duration overall and by other predictors. A series of multivariate ordinary least squares (OLS) regression models were estimated to explore predictors of change in sleep problems and change in sleep time.ResultsPeople in the UK on average experienced an increase in sleep loss during the first 4 weeks of the lockdown (mean=0.13, SD=0.9). Women report more sleep loss than men (coefficient=0.15, 95% CI 0.11 to 0.19). Daily sleep duration on average increased by ten minutes (mean=−0.16, SD=1.11), with men gaining eight more minutes of sleep per day than women (coefficient=0.13, 95% CI 0.09 to 0.17).ConclusionThe COVID-19 related measures amplified traditional gender roles. Men’s sleep was more affected by changes in their financial situation and employment status related to the crisis, with women more influenced by their emotional reaction to the pandemic, feeling anxious and spending more time on family duties such as home schooling, unpaid domestic duties, nurturing and caregiving. Based on our findings, we provide policy advice of early, clear and better employment protection coverage of self-employed and precarious workers and employer recognition for parents.

show abstract

“…However, the coronavirus disease 2019 (COVID-19) pandemic had a deleterious impact on both elective and emergent surgery. The first national lockdown was imposed in the UK on 23 March 2020 and lasted until a phased reopening throughout June 2020 [4]. A second lockdown was from the period of 5 November to 2 December 2020.…”

Section: Introductionmentioning

confidence: 99%

Percutaneous Cholecystostomy for Acute Cholecystitis: A Three-Year Single-Centre Experience Including During COVID-19

Shakir¹,

Matwala²,

Vasan³

et al. 2021

Cureus

View full text Add to dashboard Cite

IntroductionPercutaneous cholecystostomy is a recognised treatment modality for acute cholecystitis. Traditionally, its use was reserved for patients deemed unfit for surgery. However, the coronavirus disease 2019 (COVID-19) pandemic had a detrimental effect on both elective and emergency surgery. The utilisation of cholecystostomy thus increased. Unanswered questions remain over timing with respect to interval cholecystectomy. We evaluated our local practice over the preceding three years. MethodsA retrospective analysis was performed of all patients who had a percutaneous cholecystostomy inserted over a three-year period (1 January 2018-1 January 2021). The primary outcome was time to cholecystectomy. Secondary outcomes were cholecystostomy-related complications, 30-day mortality, cholecystectomy-related complications and length of postoperative hospital stay. ResultsA total of 31 patients were identified during the period. Thirteen (42%) patients went on to have a laparoscopic cholecystectomy. The median time interval from cholecystostomy to cholecystectomy was 97 days (interquartile range [IQR]: 81-140, minimum: 47 and maximum: 791). One case was complicated by small bowel perforation; this occurred after an interval of 106 days. The median length of postoperative stay was one day (IQR: 1-1, minimum: 0 and maximum: 4). Cholecystostomy-related complications were observed in four (13%) patients, whereby three became displaced and one developed blockage. Thirty-day mortality following cholecystostomy insertion was zero. ConclusionsPercutaneous cholecystostomy is a safe and effective intervention for the management of acute cholecystitis. Interval cholecystectomy should be carefully considered; it may be safer to perform prior to 90 days.

show abstract

The varying impacts of COVID-19 and its related measures in the UK: A year in review

Cited by 68 publications

References 43 publications

Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study

Post-traumatic stress symptoms in cancer patients during the COVID-19 pandemic: a one-year longitudinal study

Gender differences in sleep disruption during COVID-19: cross-sectional analyses from two UK nationally representative surveys

Percutaneous Cholecystostomy for Acute Cholecystitis: A Three-Year Single-Centre Experience Including During COVID-19

Contact Info

Product

Resources

About